Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mladen Djurasovic

Orthopaedic Surgery of the Spine Louisville, KY Medical Doctor

NPI 1609839257 CMS profile 1206064

210 E Gray St, Suite 900, Louisville, KY 40202

Open in the dashboard

General payments

$3,093,123

392 records reported · program years 2019–2025

Research payments

$950

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$10,200

1 holding reported · through program year 2025

Research they led as principal investigator

$33,565 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Mladen Djurasovic of Louisville, KY is reported in the CMS Open Payments database as having received $3,093,123 across 392 general payments and $950 in research payments paid to them. Separately, studies naming them as principal investigator received $33,565 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $10,200 across 1 holding.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $893,777 65
2024 General $963,962 67
2023 General $769,348 47
2022 General $333,758 79
2021 General $71,188 53
2020 General $42,467 51
2019 General $18,623 30
2019 Research $950 1
2025 Ownership $10,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mladen Djurasovic
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Mladen Djurasovic were reported at $893,777. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Mladen Djurasovic Orthopaedic Surgery of the Spine median Middle half National median
2019 $18,623 $2,106 $337–$18,608 $163
2020 $42,467 $1,213 $156–$15,082 $114
2021 $71,188 $1,834 $271–$15,617 $132
2022 $333,758 $2,015 $320–$17,036 $149
2023 $769,348 $1,925 $336–$14,599 $160
2024 $963,962 $2,110 $341–$12,483 $164
2025 $893,777 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $1,945,901 223 payments
  2. Globus Medical, Inc. $558,152 26 payments
  3. NuVasive, Inc. $506,021 44 payments
  4. Medtronic USA, Inc. $53,262 61 payments
  5. Stryker Corporation $17,937 14 payments
  6. Exapnding Innovations, Inc. $10,200 1 payment
  7. Alphatec Spine, Inc $273 2 payments
  8. Curiteva, Inc. $245 1 payment
  9. Spinal Elements, Inc. $185 1 payment
  10. Providence Medical Technology, Inc. $157 2 payments
  11. Other $790 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,893,332 42 payments
  2. Consulting Fee $98,195 68 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $68,570 9 payments
  4. Travel and Lodging $22,852 60 payments
  5. Food and Beverage $9,815 200 payments
  6. Education $359 13 payments
Products named General payments · program years 2019–2025
  1. Modulus Spine/Spine Surgery $1,020,320 18 payments
  2. CATALYFT PL EXPANDABLE INTERBODY SYSTEM $348,603 35 payments
  3. ALIF $118,557 14 payments
  4. TLIF $109,501 3 payments
  5. CD HORIZON Tl $34,537 36 payments
  6. CD HORIZON SPINAL SYSTEM $33,126 74 payments
  7. Modulus Spine $28,330 1 payment
  8. CD HORIZON Tl $23,460 12 payments
  9. CASCADIA INTERBODY SYSTEM $16,250 1 payment
  10. CANYON RETRACTOR SYSTEMS $16,250 1 payment
  11. Other $48,572 174 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $950 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

383

Median for Orthopedic Surgery: 203

Drug cost

$2,767

Median for Orthopedic Surgery: $1,433

Branded share of claims

15.7%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Baclofen Generic 54 $733
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 32 $480
Tizanidine Hcl Generic 63 $423
Gabapentin Generic 40 $269
Tramadol Hcl Generic 36 $192
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $182
Methylprednisolone Generic 21 $128
Cyclobenzaprine Hcl Generic 40 $116
Meloxicam Generic 57 $111
Methocarbamol Generic 12 $99

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$186,684

Medicare's payments for the services billed

Medicare patients

234

Average age 70

Services billed

972

146 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 33%
Depression 32%
Ischemic heart disease 31%
COPD 24%
Osteoporosis 23%
Chronic kidney disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

393 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record